Omitting race and ethnicity from colorectal cancer (CRC) recurrence risk prediction models could decrease their accuracy and fairness, particularly for minority groups, potentially leading to ...

Mayo Clinic researchers and NASA Frontier Development Lab scientists are working to fine-tune an artificial intelligence algorithm that detects spatio-temporal patterns related to colorectal cancer ...

Shield is the first and only blood test that has received full FDA approval as a primary screening option for CRC in average-risk adults aged 45 and older and can be ordered by any prescribing ...

Guardant Health (GH) announced a clinical readout update assessing the performance of the latest colorectal cancer screening algorithm for its ...